Would you like to establish your business at Norway's new arena for health innovation?


About the project

The potential for innovation within the Norwegian health industry is high. Increased demand for user-centric solutions alongside new welfare technology entails unique possibilities for innovation and interaction. Until now, the physical localities for such interaction has been lacking, and Gardermoen Campus aims to create this arena.

Gardermoen Campus is a large development project that will be actualised in multiple construction phases.

The Norwegian Heart and Lung Patient Organisation (LHL) clinics at Gardermoen will make up the “heart” of a business and service cluster that will have a particular focus on knowledge-based activities. The aim is for the LHL Clinics at Gardermoen to become a national powerhouse dedicated to helping sufferers of heart and lung disease from throughout Norway, with LHL becoming the co-location for Norway’s leading heart and lung specialists drawn from the Feiring and Glittre clinics. The hospital is expected to have a staff of some 500 employees and in the region of 30,000 visitors per year and will occupy approximately one quarter of the development capacity of the site.

Synergies will be achieved by attaching other functions to the LHL Clinics at Gardermoen. In addition, a municipal health centre or “health house” will be established in the immediate vicinity of the hospital. The health house and the other tenants will be able to share facilities such as a patient hotel with conference rooms, diagnostic imaging services including x-ray, ultrasound, CAT and MRI equipment, a therapy pool and exercise spaces, restaurants, and other services.

The relocation of the LHL Clinics to Gardermoen and the opening of the Health House could create the basis for a business and service cluster that embraces a large proportion of health-related businesses, such as medicine, research and development (R&D), technology, service providers, teaching, public/private health services and other knowledge-based enterprises. The cluster could also include businesses with a focus on the Gardermoen area.
Various business and service functions will provide a basis for a range of local services, including meeting places, restaurants and cafes and active outdoor spaces, to the benefit of the hospital and the surrounding community. The area offers considerable potential as a link between adjoining recreational spaces and could become a leisure destination that lies within acceptable walking and cycling distance of the residential areas in the nearby town of Jessheim, without competing with Jessheim’s position as the centre of the area.

Read more about the relocation of the LHL Clinics to Gardermoen (in Norwegian)


The area

Gardermoen Campus is located on the northbound E6 after the exit for Oslo Airport, opposite the Quality Hotel and the Esso service station. The maximum permitted development on the area is 120,000 m² of buildings, of which approximately 37,000 m² are currently under construction.

Gardermoen Campus will form part of the city of Jessheim, and will lie close to not only Jessheim town centre but also to major areas of housing. The area is also close to untouched spaces of natural beauty, such as Nordby Tarn, which is a well-known recreational area. The location of the site is such that it is not disturbed by aircraft noise, even though it lies close to and has excellent transport links with Oslo Airport.

The intention is to create an area that embodies outstanding architectural and landscape qualities. Aspelin Ramm’s prior experience from, for example, the Vulkan Project in Oslo, will be applied in lowering energy consumption and exploiting the benefits of co-locating a range of different functions. Property developers Hemfosa have extensive experience of developing a wide range of health care facilities in Sweden.

The plan for the development seeks to encourage a high degree of public transport use, strengthening of the public transport axis between Jessheim and Gardermoen. Priority will be given to green recreational areas and good pedestrian and cycle connections.

The buildings are being designed by Nordic Office of Architecture, whose past designs include St Olaf’s Hospital in Trondheim and the Oslo Airport Gardermoen expansion project. HENT, the contractor, has extensive experience of hospital projects.





The area is being developed by Gardermoen Campus Utvikling AS, which is jointly owned by Aspelin Ramm and Hemfosa Samfunnsbygg AS.

LHL-klinikkene own and operate a number of medical clinics and treatment institutions, primarily serving heart and lung patients. The LHL Clinics are a limited company owned by the Norwegian Heart and Lung Patient Organisation. This company is operated on a not-for-profit basis. The clinics have a total of 500 employees drawn from a variety of professions and the turnover of the company is in the region of NOK 600 million per annum.

Gardermoen Campus Helsehus or health house is a joint centre for co-located local medical services consisting of the health house owned by the municipalities of Nannestad, Gjerdrum, Hurdal and Ullensaker and LHL, PTØ Norge and Vitus Apotek. At the time of writing (December 2015) the health house is fully occupied, the following facilities having been let:


Municipal Health House

4.300 m²
The four municipalities that will co-locate their operations in the local medical centre housed in the health house are Nannestad, Gjerdrum, Hurdal and Ullensaker.


2.800 m²
Offices and conference centre.

PTØ Norge

850 m²
The patients treated by PTØ include children and young people suffering from cerebral palsy. PTØ’ s regional centres at Hamar and Ski are being relocated to Gardermoen Campus.


200 m²
The Vitus chain of pharmacies is owned by Norsk Medisinaldepot (NMD), which is one of Norway’s largest suppliers of pharmaceutical and health-related products. The Vitus pharmacy will be centrally located between the hospital and the health house.



Start of construction

Construction work has already started. The hospital and health house will be ready at year-end 2017‑18.